Research analysts at StockNews.com began coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Down 3.1 %
NASDAQ CHEK opened at $0.76 on Monday. Check-Cap has a 12-month low of $0.56 and a 12-month high of $3.45. The company’s 50 day moving average is $1.02 and its 200-day moving average is $1.16. The firm has a market cap of $4.42 million, a P/E ratio of -0.25 and a beta of 0.19.
Check-Cap Company Profile
Featured Articles
- Five stocks we like better than Check-Cap
- Learn Technical Analysis Skills to Master the Stock Market
- How to Build the Ultimate Everything ETF Portfolio
- What Are Dividends? Buy the Best Dividend Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Investing in the High PE Growth Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.